Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why NovoCure Stock Is Cratering Today


Shares of Novo Nordisk (NYSE: NVO) are plunging on Tuesday, down 21% as of 2:10 p.m. ET. The drop comes as the S 500 (^GSPC) and the Nasdaq Composite (^IXIC) both lost 0.3%.

The Danish pharmaceutical giant announced it was cutting its full-year guidance ahead of its upcoming earnings on Aug. 6. The news overshadowed the company's appointment of a new CEO.

On Tuesday, Novo Nordisk named Mike Doustdar as the company's new CEO. He'll begin his tenure on Aug. 7, just months after the unexpected removal of its previous CEO, Lars Fruergaard Jørgensen.

Continue reading


Source Fool.com

Like: 0
NVO
Share

Comments